SNSE stock

Sensei Biotherapeutics Inc (SNSE) financials · $18.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Sensei Biotherapeutics Inc (SNSE) $18.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$22.3M-$32.6M
Net Income-$21.1M-$30.2M
EPS (Diluted)-$16.72-$1.20
Cached annual balance sheet
LineFY2025FY2024
Total Assets$22.9M$45.4M
Current Assets$21.5M$41.9M
Cash & Equivalents$8.67M$9.99M
PP&E$82.0K$417.0K
Total Liabilities$4.31M$6.97M
Current Liabilities$4.25M$5.45M
Shareholders' Equity$18.6M$38.4M
Retained Earnings-$283.1M-$262.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$20.5M-$24.7M
CapEx$16.0K$146.0K
Investing Cash Flow$19.8M$22.4M
Financing Cash Flow-$645.0K-$787.0K
Net Change in Cash-$1.33M-$3.02M
Free Cash Flow-$20.5M-$24.8M
These statements as JSON? API free 100/day

FAQ

What is SNSE P/E and revenue?

Sensei Biotherapeutics Inc (SNSE) $18.6M cap.

What is SNSE revenue?

SNSE income-statement cache has no revenue figure yet.

Is SNSE profitable?

Sensei Biotherapeutics Inc last cached net income is -$21.1M (FY2025).

What are SNSE total assets?

Sensei Biotherapeutics Inc last cached total assets are $22.9M (FY2025).

What is SNSE free cash flow?

Sensei Biotherapeutics Inc last cached free cash flow is -$20.5M (FY2025).

Not investment advice. Cached statements, not a live tape.